Elevated frequency of loss of heterozygosity in mammary tumors arising in mouse mammary tumor virus/neu transgenic mice

Cancer Research

Volumn 59, Issue 10, 1999, Pages 2438-2444

  Cool, Marc ^a   Jolicoeur, Paul ^a,b,c  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CHROMOSOME 19; CHROMOSOME 4; CHROMOSOME 8; CHROMOSOME MAP; FEMALE; GENE DELETION; GENE FREQUENCY; HETEROZYGOSITY LOSS; MALE; MARKER GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE;

ALLELES; ANIMALS; CADHERINS; CHROMOSOME MAPPING; CROSSES, GENETIC; FEMALE; GENE DELETION; GENES, ERBB-2; GENES, P16; GENES, TUMOR SUPPRESSOR; LOSS OF HETEROZYGOSITY; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MAMMARY TUMOR VIRUS, MOUSE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC;

EID: 0033563277     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. Stern, D. F., Heffernan, P. A., and Weinberg, R. A. p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity. Mol. Cell. Biol., 6: 1729-1740, 1986.
2. Bargmann, C. I., Hung, M. C., and Weinberg, R. A. The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature (Lond.), 319: 226-230, 1986.
3. Salomon, D. S., Brandt, R., Ciardiello, F., and Normanno, N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit. Rev. Oncol. Hematol., 19: 183-232, 1995.
4. Kinzler, K. W., and Vogelstein, B. Lessons from hereditary colorectal cancer. Cell, 87: 159-170, 1996.
5. van de Vijver, M. J. Molecular genetic changes in human breast cancer. Adv. Cancer Res., 61: 25-56, 1993.
6. Bieche, I., and Lidereau, R. Genetic alterations in breast cancer. Genes Chromosomes Cancer, 14: 227-251, 1995.
7. Devilee, P., and Cornelisse, C. J. Somatic genetic changes in human breast cancer. Biochim. Biophys. Acta, 1198: 113-130, 1994.
8. Levine, A. J. The tumor suppressor genes. Annu. Rev. Biochem., 62: 623-651, 1993.
9. Rebbeck, T. R., Godwin, A. K., and Buetow, K. H. Variability in loss of constitutional heterozygosity across loci and among individuals: association with candidate genes in ductal breast carcinoma. Mol. Carcinog., 17: 117-125, 1996.
10. Kurose, K., Iida, A., Araki, T., Sakamoto, G., Kasumi, F., Nakamura, Y., and Emi, M. Frequent allelic loss at 7p14-15 associated with aggressive histologic types of breast cancer. Jpn. J. Cancer Res., 89: 533-538, 1998.
11. Driouch, K., Briffod, M., Bieche, I., Champeme, M. H., and Lidereau, R. Location of several putative genes possibly involved in human breast cancer progression. Cancer Res., 58: 2081-2086, 1998.
12. Wu, Y., Barnabas, N., Russo, I. H., Yang, X., and Russo, J. Microsatellite instability and loss of heterozygosity in chromosomes 9 and 16 in human breast epithelial cells transformed by chemical carcinogens. Carcinogenesis (Lond.), 18: 1069-1074, 1997.
13. Loupart, M. L., Adams, S., Armour, J. A., Walker, R., Brammar, W., and Varley, J. Loss of heterozygosity on the X chromosome in human breast cancer. Genes Chromosomes Cancer, 13: 229-238, 1995.
14. Knudson, A. G. Antioncogenes and human cancer. Proc. Natl. Acad. Sci. USA, 90: 10914-10921, 1993.
15. Knudson, A. G., Jr. The genetics of childhood cancer. Cancer (Phila.), 35: 1022-1026, 1975.
16. Prosser, J., Thompson, A. M., Cranston, G., and Evans, H. J. Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours. Oncogene, 5: 1573-1579, 1990.
17. Lee, E. Y., To, H., Shew, J. Y., Bookstein, R., Scully, P., and Lee, W. H. Inactivation of the retinoblastoma susceptibility gene in human breast cancers. Science (Washington DC), 241: 218-221, 1988.
18. T'Ang, A., Varley, J. M., Chakraborty, S., Murphree, A. L., and Fung, Y. K. Structural rearrangement of the retinoblastoma gene in human breast carcinoma. Science (Washington DC), 242: 263-266, 1988.
19. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S. H., Giovanella, B. C., Ittmann, M., Tycko, B., Hibshoosh, H., Wigler, M. H., and Parsons, R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science (Washington DC), 275: 1943-1947, 1997.
20. Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., Frye, C., Hu, R., Swedlund, B., Teng, D. H., and Tavtigian, S. V. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet., 15: 356-362, 1997.
21. Berx, G., Cleton-Jansen, A. M., Strumane, K., de Leeuw, W. J., Nollet, F., van Roy, F., and Cornelisse, C. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene, 13: 1919-1925, 1996.
22. Berx, G., Cleton-Jansen, A. M., Nollet, F., de Leeuw, W. J., van de Vijver, M., Cornelisse, C., and van Roy, F. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J., 14: 6107-6115, 1995.
23. Man, S., Ellis, I. O., Sibbering, M., Blamey, R. W., and Brook, J. D. High levels of allele loss at the FHIT and ATM genes in non-comedo ductal carcinoma in situ and grade I tubular invasive breast cancers. Cancer Res., 56: 5484-5489, 1996.
24. Negrini, M., Monaco, C., Vorechovsky, I., Ohta, M., Druck, T., Baffa, R., Huebner, K., and Croce, C. M. The fhit gene at 3p14.2 is abnormal in breast carcinomas. Cancer Res., 56: 3173-3179, 1996.
25. Li, L., Li, X., Francke, U., and Cohen, S. N. The TSG101 tumor susceptibility gene is located in chromosome 11 band p15 and is mutated in human breast cancer. Cell, 88: 143-154, 1997.
26. Brenner, A. J., and Aldaz, C. M. Chromosome 9p allelic loss and p16/CDKN2 in breast cancer and evidence of p16 inactivation in immortal breast epithelial cells. Cancer Res., 55: 2892-2895, 1995.
27. Xu, L., Sgroi, D., Sterner, C. J., Beauchamp, R. L., Pinney, D. M., Keel, S., Ueki, K., Rutter, J. L., Buckler, A. J., and Louis, D. N. Mutational analysis of CDKN2 (MTS1/p16ink4) in human breast carcinomas. Cancer Res., 54: 5262-5264, 1994.
28. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K. T., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., Bell, R., Rosenthal, J., Hussey, C., Tran, T., McClure, M., Frye, C., Hattier, T., Phelps, R., Haugen-Strano, A., Katcher, H., Yakumo, K., Gholami, Z., Shaffer, D., Stone, S., Bayer, S., Wray, C., Bogden, R., Dayananth, P., Ward, J., Tonin, P., Narod, S., Bristow, P. K., Norris, F. H., Helvering, L., Morrison, P., Rosteck, P., Lai, M., Barrett, J. C., Lewis, C., Neuhausen, S., Cannon-Albright, L., Goldgar, D., Wiseman, R., Kamb, A., and Skolnick, M. H. A strong candidate for the breast and ovarian cancer susceptibility gene BRCAI. Science (Washington DC), 266: 66-71, 1994.
29. Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., Micklem, G., Barfoot, R., Hamoudi, R., Patel, S., Rice, C., Biggs, P., Hashim, Y., Smith, A., Connor, F., Arason, A., Gudmundsson, J., Ficenec, D., Kelsell, D., Ford, D., Tonin, P., Bishop, D. T., Spurr, N. K., Ponder, B. A. J., Eeles, R., Peto, J., Devilee, P., Cornelisse, C., Lynch, H., Narod, S., Lenoir, G., Egilsson, V., Barkadottir, R. B., Easton, D. F., Bentley, D. R., Futreal, P. A., Ashworth, A., and Stratton, M. R. Identification of the breast cancer susceptibility gene brca2. Nature (Lond.), 378: 789-792, 1995.
30. Bouchard, L., Lamarre, L., Tremblay, P. J., and Jolicoeur, P. Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene. Cell, 57: 931-936, 1989.
31. Muller, W. J., Sinn, E., Pattengale, P. K., Wallace, R., and Leder, P. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell, 54: 105-115, 1988.
32. Webster, M. A., and Muller, W. J. Mammary tumorigenesis and metastasis in transgenic mice. Semin. Cancer Biol., 5: 69-76, 1994.
33. Poirier, Y., and Jolicoeur, P. Distinct helper virus requirements for Abelson murine leukemia virus-induced pre-B-and T-cell lymphomas. J. Virol., 63: 2088-2098, 1989.
34. Dietrich, W. F., Miller, J. C., Steen, R. G., Merchant, M., Damron, D., Nahf, R., Gross, A., Joyce, D. C., Wessel, M., Dredge, R. D., Marquis, A., Stein, L. D., Goodman, N., Page, D. C., and Lander, E. S. A genetic map of the mouse with 4,006 simple sequence length polymorphisms. Nat. Genet., 5: 220-245, 1994.
35. Dietrich, W. F., Miller, J., Steen, R., Merchant, M. A., Damron-Boles, D., Husain, Z., Dredge, R., Daly, M. J., Ingalls, K. A., O'Connor, T. J., Evans, C. A., DeAngelis, M. M., Levinson, D. M., Kruglyak, L., Goodman, N., Copeland, N. G., Jenkins, N. A., Hawkins, T. L., Stein, L., Page, D. C., and Lander, E. S. A comprehensive genetic map of the mouse genome. Nature (Lond.), 380: 149-152, 1996.
36. Driouch, K., Dorion-Bonnet, F., Briffod, M., Champeme, M. H., Longy, M., and Lidereau, R. Loss of heterozygosity on chromosome arm 16q in breast cancer metastases. Genes Chromosomes Cancer, 19: 185-191, 1997.
37. Kremmidiotis, G., Baker, E., Crawford, J., Eyre, H. J., Nahmias, J., and Callen, D. F. Localization of human cadherin genes to chromosome regions exhibiting cancer-related loss of helerozygosity. Genomics, 49: 467-471, 1998.
38. Manenti, G., De Gregorio, L., Gariboldi, M., Dragani, T. A., and Pierotti, M. A. Analysis of loss of heterozygosity in murine hepatocellular tumors. Mol. Carcinog., 13: 191-200, 1995.
39. Devereux, T. R., Wiseman, R. W., Kaplan, N., Garren, S., Foley, J. F., White, C. M., Anna, C., Watson, M. A., Patel, A., Jarchow, S., Maronpot, R. R., and Anderson, M. W. Assignment of a locus for mouse lung tumor susceptibility to proximal chromosome 19. Mamm. Genome, 5: 749-755, 1994.
40. Festing, M. F., Yang, A., and Malkinson, A. M. At least four genes and sex are associated with susceptibility to urethane-induced pulmonary adenomas in mice. Genet. Res., 64: 99-106, 1994.
41. Radany, E. H., Hong, K., Kesharvarzi, S., Lander, E. S., and Bishop, J. M. Mouse mammary tumor virus/v-Ha-ras transgene-induced mammary tumors exhibit strain-specific allefic loss on mouse chromosome 4. Proc. Natl. Acad. Sci. USA, 94: 8664-8669, 1997.
42. Ritland, S. R., Rowse, G. J., Chang, Y., and Gendler, S. J. Loss of heterozygosity analysis in primary mammary tumors and lung metastases of MMTV-MTAg and MMTV-neu transgenic mice. Cancer Res., 57: 3520-3525, 1997.
43. Aldaz, C. M., Liao, Q. Y., Paladugu, A., Rehm, S., and Wang, H. Allelotypic and cytogenetic characterization of chemically induced mouse mammary tumors: high frequency of chromosome 4 loss of heterozygosity at advanced stages of progression. Mol. Carcinog., 17: 126-133, 1996.
44. Wiseman, R. W., Cochran, C., Dietrich, W., Lander, E. S., and Soderkvist, P. Allelotyping of butadiene-induced lung and mammary adenocarcinomas of B6C3F1 mice: frequent losses of heterozygosity in regions homologous to human tumor-suppressor genes. Proc. Natl. Acad. Sci. USA, 91: 3759-3763, 1994.
45. Rochelle, J. M., Watson, M. L., Oakey, R. J., and Seldin, M. F. A linkage map of mouse chromosome 19: definition of comparative mapping relationships with human chromosomes 10 and 11 including the MEN1 locus. Genomics, 14: 26-31, 1992.
46. Eagle, L. R., Yin, X., Brothman, A. R., Williams, B. J., Atkin, N. B., and Prochownik, E. V. Mutation of the MXI1 gene in prostate cancer. Nat. Genet., 9: 249-255, 1995.
47. Mollenhauer, J., Wiemann, S., Scheurlen, W., Korn, B., Hayashi, Y., Wilgenbus, K. K., von Deimling, A., and Poustka, A. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours. Nat. Genet., 17: 32-39, 1997.
48. Nakamura, H., Yoshida, M., Tsuiki, H., Ito, K., Ueno, M., Nakao, M., Oka, K., Tada, M., Kochi, M., Kuratsu, J., Ushio, Y., and Saya, H. Identification of a human homolog of the Drosophila neuralized gene within the 10q25.1 malignant astrocytoma deletion region. Oncogene, 16: 1009-1019, 1998.
49. Santos, J., Perez de Castro, I., Herranz, M., Pellicer, A., and Fernandez-Piqueras, J. Allelic losses on chromosome 4 suggest the existence of a candidate tumor suppressor gene region of about 0.6 cM in gamma-radiation-induced mouse primary thymic lymphomas. Oncogene, 12: 669-676, 1996.
50. Zhuang, S. M., Eklund, L. K., Cochran, C., Rao, G. N., Wiseman, R. W., and Soderkvist, P. Allelotype analysis of 2′,3′-dideoxycytidine-and 1,3-butadiene-induced lymphomas in B6C3F1 mice. Cancer Res., 56: 3338-3343, 1996.
51. Herzog, C. R., Wang, Y., and You, M. Allelic loss of distal chromosome 4 in mouse lung tumors localize a putative tumor suppressor gene to a region homologous with human chromosome 1p36. Oncogene, 11: 1811-1815, 1995.
52. Sheng, Z. M., Marchetti, A., Buttitta, F., Champeme, M. H., Campani, D., Bistocchi, M., Lidereau, R., and Callahan, R. Multiple regions of chromosome 6q affected by loss of heterozygosity in primary human breast carcinomas. Br. J. Cancer, 73: 144-147, 1996.
53. Pabst, T., Schwaller, J., Bellomo, M. J., Oestreicher, M., Muhlematter, D., Tichelli, A., Tobler, A., and Fey, M. F. Frequent clonal loss of heterozygosity but scarcity of microsatellite instability at chromosomal breakpoint cluster regions in adult leukemias. Blood, 88: 1026-1034, 1996.
54. Habuchi, T., Luscombe, M., Elder, P. A., and Knowles, M. A. Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32-q33. Genomics, 48: 277-288, 1998.
55. Miyasaka, K., Ohtake, K., Nomura, K., Kanda, H., Kominami, R., Miyashita, N., and Kitagawa, T. Frequent loss of heterozygosity on chromosome 4 in diethylnitrosamine-induced C3H/MSM mouse hepatocellular carcinomas in culture. Mol. Carcinog., 13: 37-43, 1995.
56. Miyasaka, K., and Kawauchi, S. Homozygous deletion of mouse homolog of p16/ CDKN2 gene on chromosome 4 in mouse liver epithelial cells in culture. Biol. Pharm. Bull., 19: 345-349, 1996.
57. Miyasaka, K., Fukui, T., and Kitagawa, T. Allelotype analysis in mouse hepatocellular carcinomas: frequent homozygous deletion of mouse homolog of p16/CDKN2 gene on chromosome 4 in culture. Biol. Pharm. Bull., 19: 683-691, 1996.
58. Lander, J. K., and Fan, H. Low-frequency loss of heterozygosity in Moloney murine leukemia virus-induced tumors in BRAKF1/J mice. J. Virol., 71: 3940-3952, 1997.
59. Herzog, C. R., Chen, B., Wang, Y., Schut, H. A., and You, M. Loss of heterozygosity on chromosomes 1, 11, 12, and 14 in hybrid mouse lung adenocarcinomas. Mol. Carcinog., 16: 83-90, 1996.
60. Herzog, C. R., Wiseman, R. W., and You, M. Deletion mapping of a putative tumor suppressor gene on chromosome 4 in mouse lung tumors. Cancer Res., 54: 4007-4010, 1994.
61. Hegi, M. E., Devereux, T. R., Dietrich, W. F., Cochran, C. J., Lander, E. S., Foley, J. F., Maronpot, R. R., Anderson, M. W., and Wiseman, R. W. Allelotype analysis of mouse lung carcinomas reveals frequent allelic losses on chromosome 4 and an association between allelic imbalances on chromosome 6 and K-ras activation. Cancer Res., 54: 6257-6264, 1994.
62. Herzog, C. R., Soloff, E. V., McDoniels, A. L., Tyson, F. L., Malkinson, A. M., Haugen-Strano, A., Wiseman, R. W., Anderson, M. W., and You, M. Homozygous codeletion and differential decreased expression of p15INK4b, p16INK4a-α and p16INK4a-β in mouse lung tumor cells. Oncogene, 13: 1885-1891, 1996.
63. Hussain, S. P., and Harris, C. C. Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes. Cancer Res., 58: 4023-4037, 1998.
64. Eiriksdottir, G., Sigurdsson, A., Jonasson, J. G., Agnarsson, B. A., Sigurdsson, H., Gudmundsson, J., Bergthorsson, J. T., Barkardottir, R. B., Egilsson, V., and Ingvarsson, S. Loss of heterozygosity on chromosome 9 in human breast cancer: association with clinical variables and genetic changes at other chromosome regions. Int. J. Cancer, 64: 378-382, 1995.
65. Van Zee, K. J., Calvano, J. E., and Bisogna, M. Hypomethylation and increased gene expression of p16INK4a in primary and metastatic breast carcinoma as compared to normal breast tissue. Oncogene, 16: 2723-2727, 1998.
66. Lee, G. H., Ogawa, K., Nishimori, H., and Drinkwater, N. R. Most liver epithelial cell lines from C3B6F1 mice exhibit parentally-biased loss of heterozygosity at the Lci (Liver cell immortalization) locus on chromosome 4. Oncogene, 11: 2281-2287, 1995.
67. Phelan, C. M., Larsson, C., Baird, S., Futreal, P. A., Ruttledge, M. H., Morgan, K., Tonin, P., Hung, H., Korneluk, R. G., Pollak, M. N., and Narod, S. A. The human mammary-derived growth inhibitor (MDGI) gene: genomic structure and mutation analysis in human breast tumors. Genomics, 34: 63-68, 1996.
68. Van Camp, G., Coucke, P., Speleman, F., Van Roy, N., Beyer, E. C., Oostra, B. A., and Willems, P. J. The gene for human gap junction protein connexin37 (GJA4) maps to chromosome 1p35.1 in the vicinity of D1S195. Genomics, 30: 402-403, 1995.
69. MacPhee, M., Chepenik, K. P., Liddell, R. A., Nelson, K., Siracusa, L. D., and Buchberg, A. M. The secretory phospholipase A2 gene is a candidate for the MomI locus, a major modifier of ApcMin-induced intestinal neoplasia. Cell, 81: 957-966, 1995.
70. Dietrich, W. F., Lander, E. S., Smith, J. S., Moser, A. R., Gould, K. A., Luongo, C., Borenstein, N., and Dove, W. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell, 75: 631-639, 1993.
71. Praml, C., Savelyeva, L., Le Paslier, D., Siracusa, L. D., Buchberg, A. M., Schwab, M., and Amler, L. C. Human homologue of a candidate for the mom1 locus, the secretory type II phospholipase a2 (pla2s-II), maps to 1p35-36.1/d1s199. Cancer Res., 55: 5504-5506, 1995.
72. Nagai, H., Negrini, M., Carter, S. L., Gillum, D. R., Rosenberg, A. L., Schwartz, G. F., and Croce, C. M. Detection and cloning of a common region of loss of heterozygosity at chromosome Ip in breast cancer. Cancer Res., 55: 1752-1757, 1995.
73. Tsukamoto, K., Ito, N., Yoshimoto, M., Kasumi, F., Akiyama, F., Sakamoto, G., Nakamura, Y., and Emi, M. Allelic loss on chromosome 1p is associated with progression and lymph node metastasis of primary breast carcinoma. Cancer (Phila.), 82: 317-322, 1998.
74. Lahti, J. M., Valentine, M., Xiang, J., Jones, B., Amann, J., Grenet, J., Richmond, G., Look, A. T., and Kidd, V. J. Alterations in the PITSLRE protein kinase gene complex on chromosome 1p36 in childhood neuroblastoma. Nat. Genet., 7: 370-375, 1994.
75. Pekarsky, Y., Druck, T., Cotticelli, M. G., Ohta, M., Shou, J., Mendrola, J., Montgomery, J. C., Buchberg, A. M., Siracusa, L. D., Manenti, G., Fong, L. Y., Dragani, T. A., Croce, C. M., and Huebner, K. The murine Fhit locus: isolation, characterization, and expression in normal and tumor cells. Cancer Res., 58: 3401-3408, 1998.